In this study, low expression of JWA mRNA was significantly correlated with increased mOS in patients treated with cisplatin-based regimens but not in those treated with docetaxel-based regimens though JWA was identified as microtubule-associated protein, which was consistent with the current evidence for the predictive value of JWA in resectable gastric cancer that underwent platinum-based adjuvant chemotherapy [23,25,42]. Here, ARL6IP5 is linked to gastric cancer.